Global Opioids Market (2022 to 2027) – Players Include Pfizer, Purdue Pharmaceuticals, Rhodes Technologies and Sun Pharmaceutical Industries – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Global Opioids Market (2022-2027) by Product Type, Receptor Binding, Application, Geography, Competitive Analysis and the Impact of Covid-19 with Ansoff Analysis” report has been added to ResearchAndMarkets.com’s offering. The Global Opioids Market is estimated to be USD 5.1 Bn in 2022 and is expected to reach USD 6.29 Bn by 2027, growing at … [Read more…]

Confluent Medical Technologies Announces Grand Opening of Costa Rica Expansion

Confluent Medical Technologies Announces the Grand Opening of the Newest Building at Their Large Scale Manufacturing Center of Excellence in Alajuela, Costa Rica SCOTTSDALE, Ariz.–(BUSINESS WIRE)–#Catheter–Confluent Medical Technologies (Confluent), today announced the Grand Opening of the latest addition to their large scale manufacturing center of excellence in Alajuela, Costa Rica, expanding their capacity for Nitinol … [Read more…]

Virtual Clinical Trials Global Market Report 2022: Increase in Investments from Governments and Pharmaceutical Companies in Vaccine and Drug R&D Fueling Growth – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Virtual Clinical Trials Global Market Report 2022” report has been added to ResearchAndMarkets.com’s offering. The global virtual clinical trials market is expected to grow from $8.85 billion in 2021 to $9.61 billion in 2022 at a compound annual growth rate (CAGR) of 8.68%. The virtual clinical trials market is expected to grow to … [Read more…]

NIH awards Feinstein Institutes $3.8M to study radiation exposure and sepsis

MANHASSET, N.Y.–(BUSINESS WIRE)–Terrorism, acts of war, nuclear power plant malfunctions; the risk of massive radiation exposure is ever-present. Scientists from The Feinstein Institutes for Medical Research have been awarded a five-year, $3.8 million grant from the National Institutes of Health (NIH) to study how radiation affects the human body’s immune system and how to better … [Read more…]

Animal Testing And Non-Animal Alternative Testing Global Market Report 2022: Alternative Sector Driven by the Adoption of 3R Principles While Animal Testing is Boosted by Rising R&D Spending – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Animal Testing And Non-Animal Alternative Testing Global Market Opportunities And Strategies To 2035” report has been added to ResearchAndMarkets.com’s offering. Animal Testing The global animal testing market was valued at $10.74 billion in 2019 and the market is expected to grow at a compound annual growth rate (CAGR) of 4.27% during 2019-2025 and … [Read more…]

$118.57 Billion In Vitro Diagnostics (IVD) Markets by Product & Service, Technique, Application, and End User – Global Opportunity Analysis and Industry Forecast, 2022 – 2030 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “In Vitro Diagnostics Market by Product & Service, Technique, Application, and End User: Global Opportunity Analysis and Industry Forecast, 2022 – 2030” report has been added to ResearchAndMarkets.com’s offering. At an estimated value of over USD 86.51 billion in 2021, the Global In Vitro Diagnostics (IVD) Market is predicted to thrive at a … [Read more…]

NIHR and Sanofi Announce First Patient Enrolled in Large European Clinical Study to Investigate Protection Against RSV, the Leading Cause of Infant Hospitalisation Worldwide

READING, England–(BUSINESS WIRE)–Sanofi (EURONEXT: SAN and NASDAQ: SNY) and the National Institute for Health and Care Research (NIHR) have today announced that the first patient has been enrolled in the Hospitalised RSV Monoclonal Antibody Prevention (HARMONIE) study. The large European interventional clinical study is investigating protection against Respiratory syncytial virus (RSV) in infants. HARMONIE is … [Read more…]

Therapeutic Solutions International Reports Superior Efficacy of ApoptoCyte™ on Chronic Obstructive Pulmonary Disease Model Compared to Conventional Stem Cell Approaches

Phase III Clinical Stage Company Demonstrates Superior Efficacy of Proprietary Stem Cell Apoptotic Body Based Drug ELK CITY, Idaho–(BUSINESS WIRE)–Therapeutic Solutions International announced today new data demonstrating superior effects of the Company’s ApoptoCyte™ procedure treated JadiCell™ product compared to other stem cells in treating an animal model of Chronic Obstructive Pulmonary Disease (COPD). In a … [Read more…]

Humana to Expand Medicaid Services in Wisconsin with Acquisition of Inclusa, Inc.

LOUISVILLE, Ky.–(BUSINESS WIRE)–Humana Inc. (NYSE: HUM) announced today that it will acquire substantially all of the assets of Inclusa, Inc., a Managed Care Organization (“MCO”) in Wisconsin that provides long-term care services and supports to approximately 16,600 older adults and adults with disabilities through the state’s Family Care program. For more than 20 years, Inclusa … [Read more…]

Global Diabetes Diagnostics Market Report 2022: Increasing Obesity Levels Underpin Growth – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Diabetes Diagnostics – Global Market Trajectory & Analytics” report has been added to ResearchAndMarkets.com’s offering. Global Diabetes Diagnostics Market to Reach $42.4 Billion by 2026 Diabetes diagnostics systems are used to measure blood glucose levels or blood sugar levels, which indicates whether or not a person is suffering from diabetes. Demand for diabetes … [Read more…]